# Oral Ketamine for Treatment of Vaso-Occlusive Pain

> **NCT05378555** · PHASE3 · RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Vaso-occlusive Crisis

## Interventions

- **DRUG:** Ketamine Hydrochloride

## Key facts

- **NCT ID:** NCT05378555
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05378555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05378555, "Oral Ketamine for Treatment of Vaso-Occlusive Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05378555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*